7-100738501-C-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003386.3(ZAN):c.654C>A(p.Asp218Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,488,002 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003386.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZAN | NM_003386.3 | c.654C>A | p.Asp218Glu | missense_variant | 7/48 | ENST00000613979.5 | NP_003377.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZAN | ENST00000613979.5 | c.654C>A | p.Asp218Glu | missense_variant | 7/48 | 1 | NM_003386.3 | ENSP00000480750 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000424 AC: 6AN: 141422Hom.: 0 Cov.: 25
GnomAD3 exomes AF: 0.0000161 AC: 3AN: 186412Hom.: 1 AF XY: 0.0000200 AC XY: 2AN XY: 99872
GnomAD4 exome AF: 0.0000223 AC: 30AN: 1346580Hom.: 5 Cov.: 30 AF XY: 0.0000165 AC XY: 11AN XY: 667106
GnomAD4 genome AF: 0.0000424 AC: 6AN: 141422Hom.: 0 Cov.: 25 AF XY: 0.0000290 AC XY: 2AN XY: 68964
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | The c.654C>A (p.D218E) alteration is located in exon 7 (coding exon 6) of the ZAN gene. This alteration results from a C to A substitution at nucleotide position 654, causing the aspartic acid (D) at amino acid position 218 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at